| pubmed-article:16339790 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0007202 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0033618 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0033487 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0032120 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:16339790 | lifeskim:mentions | umls-concept:C0445103 | lld:lifeskim |
| pubmed-article:16339790 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16339790 | pubmed:dateCreated | 2006-1-17 | lld:pubmed |
| pubmed-article:16339790 | pubmed:abstractText | During normothermic cardiopulmonary bypass (CPB), the effect on propofol pharmacokinetics of changes in its binding to plasma proteins is consistent with the predictions of the well-stirred model of hepatic elimination for nonrestrictively cleared drug. However, whether changes in binding lead to clinically significant changes in the drug effect remains unclear. The purpose of this study was to assess changes in the drug effect of propofol in response to altered plasma binding using quantitative EEG measurements. | lld:pubmed |
| pubmed-article:16339790 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16339790 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16339790 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16339790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16339790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16339790 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16339790 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16339790 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16339790 | pubmed:issn | 0007-0912 | lld:pubmed |
| pubmed-article:16339790 | pubmed:author | pubmed-author:GotoFF | lld:pubmed |
| pubmed-article:16339790 | pubmed:author | pubmed-author:HiraokaHH | lld:pubmed |
| pubmed-article:16339790 | pubmed:author | pubmed-author:TakizawaEE | lld:pubmed |
| pubmed-article:16339790 | pubmed:author | pubmed-author:TakizawaDD | lld:pubmed |
| pubmed-article:16339790 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16339790 | pubmed:volume | 96 | lld:pubmed |
| pubmed-article:16339790 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16339790 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16339790 | pubmed:pagination | 179-85 | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:meshHeading | pubmed-meshheading:16339790... | lld:pubmed |
| pubmed-article:16339790 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16339790 | pubmed:articleTitle | Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass. | lld:pubmed |
| pubmed-article:16339790 | pubmed:affiliation | Department of Anaesthesiology, Saitama Cardiovascular and Pulmonary Centre, 1696 Itai Konan-machi Osato-gun, Saitama 360-0105, Japan. | lld:pubmed |
| pubmed-article:16339790 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16339790 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16339790 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16339790 | lld:pubmed |
